Weight Loss Clinic
Looking to shed some extra pounds? Whether it's for health reasons, improved confidence, or a special occasion, embarking on a weight loss journey can be both challenging and rewarding. From enhancing physical fitness to boosting self-esteem, there are numerous reasons why people strive to achieve their weight loss goals.
Who is eligible for Weight Loss Treatment?
At Yorkshire Pharmacy Clinic, we offer various weight loss treatments tailored to individuals with high BMIs.
Mounjaro® and Wegovy® are recommended for those with a BMI exceeding 30, or between 27 and 30 if there are associated risk factors.
Orlistat and Xenical® can be prescribed for individuals with a BMI over 30, or over 28 if there are additional risk factors such as hypertension.
During your consultation, we'll inquire about your current medications and any existing health conditions. The information provided will be used to ensure the safety and suitability of the requested treatment.
How do weight loss injections work?
Mounjaro® and Wegovy® are two weight loss injections (pens) designed to aid in weight management by suppressing appetite. These medications help individuals feel less hungry and achieve a sensation of fullness more quickly, thereby supporting efforts to control food intake and reduce calorie consumption.
What is Mounjaro?
Mounjaro is the latest cutting-edge advancement in weight loss treatment through injection pens, demonstrating an impressive average body weight loss of approximately 20% in clinical trials. The key ingredient in Mounjaro is Tirzepatide.
Administration:
Mounjaro is administered as weekly via an injectable pen.
Active Ingredient:
Tirzepatide is the active ingredient in Mounjaro, which helps regulate appetite and support weight loss.
Dosage:
Mounjaro starts at a low dose of 2.5mg, gradually increasing up to a maintenance dose of 15mg to minimise side effects.
Effectiveness:
Mounjaro has been shown to aid in significant weight loss, with clinical trials indicating up to a 20% reduction in body weight, making it a valuable option for weight management.
Prescription Criteria:
Prescribed for individuals with a BMI of 30 and above or a BMI between 27 and 30 with weight related health issues, under the supervision of a healthcare professional.
Common Side Effects:
Common side effects include nausea, vomiting, diarrhoea, and constipation.
What is Wegovy?
Wegovy, a newly available injectable weight loss medication in the UK, offers promising outcomes for individuals striving to reduce excess body weight.
Administration:
Wegovy is administered weekly via an injectable pen.·
Active Ingredient:
Semaglutide is the active ingredient in Wegovy, which regulates hunger, leading to reduced calorie intake and increased chances of weight loss.
Effectiveness:
Clinical trials have shown that Wegovy can help the average patient achieve up to a 15% reduction in body weight. This potential for significant weight loss could revolutionise weight management strategies globally, aiding many patients in effectively managing their weight.
Dosage:
Wegovy is initiated at a low dose and gradually increased to a maintenance dose up to 2.4mg to minimise potential side effects.
Prescription Criteria:
It is prescribed to individuals with a BMI of over 30 or above 27 with additional risk factors, under the supervision of a healthcare professional.
Common Side Effects:
Some common side effects of Wegovy may include nausea, vomiting, diarrhoea, or constipation.
Select the condition for which you require treatment. We prescribe medication for a range of conditions
Our clinical prescribing team will contact you same day, to assess your condition and needs. Telephone and in person consultations available
Once approved, your mediciation will be available to collect in-store.